Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Actuant Executives Adopt 10b5-1 Plans - Quick Facts

RELATED NEWS
Trade ATU now with 

Actuant Corp. (ATU: Quote) announced that certain of its executives have adopted prearranged trading plans in accordance with guidelines specified by Rule 10b5-1 under the Securities Exchange Act of 1934 and the Company's policies with respect to insider sales.

As per the 10b5-1 plans, the executives (Arzbaecher, Goldstein, Kobylinski, Lampereur) will be exercising stock options and immediately selling the shares of Actuant stock because the underlying options are approaching the end of their 10 year term. In addition, Arzbaecher and Boel plan to sell certain shares held outright. The transactions may take place from time-to-time on or after April 5, 2012, subject to certain 10b5-1 plan criteria, including certain minimum price levels and daily volume activity.

Click here to receive FREE breaking news email alerts for Actuant Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After turning lower over the course of the previous session, stocks showed a substantial move back to the upside during trading on Thursday. The gains more than offset yesterday's loss, extending the recovery from the recent sell-off. Alaska Congressman Don Young, R-Ak., is once again making headlines with comments linking the state's high suicide rate to an increase in government assistance. Young told an audience at a senior center on Wednesday that the suicide problem didn't exist until there was "largesse" from the government. Suggesting moderate growth in the short-term, the Conference Board released a report on Thursday showing that its index of leading U.S. economic indicators rose by more than economists had anticipated in the month of September.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.